Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Opinion
  • Published:

Standardization of HbA1c: good or bad?

Nature Reviews Endocrinology volume 6, pages 408–411 (2010)Cite this article

Subjects

Abstract

The development of a true reference measurement system by the International Federation for Clinical Chemistry (IFCC) for the first time allows reporting of true HbA1c results, standardized to an absolute value, worldwide. Regression equations between the IFCC assay and current harmonization assays, including the Diabetes Control and Complications Trial (DCCT) assay, are linear, tight, and stable over time. National and international setting of targets, audit and benchmarking of services will be easier than before, as will translation of research into clinical practice. Nevertheless, the main disadvantage of the IFCC assay is that the numbers and units reported (mmol/mol) are very different from the DCCT value (percentage). An extensive education program for patients and health-care professionals is, therefore, needed to prevent confusion and consequent deterioration in glycemic control. Furthermore, the IFCC system does not overcome difficulties inherent in the measurement and interpretation of HbA1c, such as in the presence of abnormal turnover of red blood cells and hemoglobinopathies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. [No authors listed] The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 329, 977–986 (1993).

  2. [No authors listed] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837–853 (1998).

  3. Jeffcoate, S. L. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet. Med. 21, 657–665 (2004).

    Article  CAS  PubMed  Google Scholar 

  4. Huisman, T. H. & Dozy, A. M. Studies on the heterogeneity of hemoglobin. V. Binding of hemoglobin with oxidized glutathione. J. Lab. Clin. Med. 60, 302–319 (1962).

    CAS  PubMed  Google Scholar 

  5. Rahbar, S. Hemoglobin H disease in two Iranian families. Clin. Chim. Acta 20, 381–385 (1968).

    Article  CAS  PubMed  Google Scholar 

  6. Rahbar, S., Blumenfeld, O. & Ranney, H. M. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 36, 838–843 (1969).

    Article  CAS  PubMed  Google Scholar 

  7. Bunn, H. F., Haney, D. N., Kamin, S., Gabbay, K. H. & Gallop, P. M. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J. Clin. Invest. 57, 1652–1659 (1976).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Little, R. R. et al. The national glycohemoglobin standardization program: a five-year progress report. Clin. Chem. 47, 1985–1992 (2001).

    CAS  PubMed  Google Scholar 

  9. American Diabetes Association. Position statement: tests of glycemia in diabetes. Diabetes Care 21, S69–S71 (1998).

  10. National Glycohemoglobin Standardization Program (NGSP) Harmonizing glycated hemoglobin testing [online], (2010).

  11. Eckerbom, S., Bergqvist, Y. & Jeppsson, J. O. Improved method for analysis of glycated haemoglobin by ion exchange chromatography. Ann. Clin. Biochem. 31, 355–360 (1994).

    Article  CAS  PubMed  Google Scholar 

  12. Shima, K. et al. Interlaboratory differences in HbA1c measurement in Japan, an interim report of the committee on an interlaboratory standardization of HbA1c determination, the Japan Diabetes Society. J. Japan. Diab. Soc. 37, 233–243 (1994).

    Google Scholar 

  13. Shima, K. et al. Interlaboratory differences in GHb measurement in Japan, the fifth report of the GHb standardization committee, the Japan Diabetes Society. J. Japan. Diab. Soc. 41, 317–323 (1998).

    Google Scholar 

  14. Sacks, D. B. et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin. Chem. 48, 436–472 (2002).

    CAS  PubMed  Google Scholar 

  15. Hoelzel, W. & Miedema, K. Development of a reference system for the international standardisation of HbA1c/glycohemoglobin determinations. J. Int. Fed. Clin. Chem. 9, 62–67 (1996).

    Google Scholar 

  16. Miedema, K. Towards worldwide standardisation of HbA1c determination. Diabetologia 47, 1143–1148 (2004).

    Article  CAS  PubMed  Google Scholar 

  17. Hanas, R. Psychological impact of changing the scale of reported HbA1c results affects metabolic control. Diabetes Care 25, 2110–2111 (2002).

    Article  PubMed  Google Scholar 

  18. International Federation of Clinical Chemistry and Laboratory Medicine. Recommendation for term and measurement unit for “HbA1c”. Clin. Chem. Lab. Med. 45, 1081–1082 (2007).

  19. American Diabetes Association. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 50, 2042–2043 (2007).

  20. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 32, 1327–1334 (2009).

  21. Heisler, M., Piette, J. D., Spencer, M., Kieffer, E. & Vijan, S. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabetes Care 28, 816–822 (2005).

    Article  PubMed  Google Scholar 

  22. UK Department of Health NHS diabetes [online], (2010).

  23. Diabetes UK. Guide to diabetes [online], (2010).

  24. Goldstein, D. E. et al. Tests of glycemia in diabetes. Diabetes Care 27, 1761–1773 (2004).

    Article  PubMed  Google Scholar 

  25. O'Kane, M. J., Lynch, P. L., Moles, K. W. & Magee, S. E. Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin. Chim. Acta 311, 157–159 (2001).

    Article  CAS  PubMed  Google Scholar 

  26. Monnier, L., Colette, C. & Owens, D. R. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J. Diabetes Sci. Technol. 2, 1094–1100 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Research Group, Institute of Cellular Medicine, Newcastle University, Floor 4, Leech Building, Faculty of Clinical Medical Sciences, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK

    Sally M. Marshall

Authors
  1. Sally M. Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

Sally M. Marshall is a consultant for Diabetes UK and the UK Department of Health.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, S. Standardization of HbA1c: good or bad?. Nat Rev Endocrinol 6, 408–411 (2010). https://doi.org/10.1038/nrendo.2010.66

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2010.66

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing